BioPharma

02 October, 2026 | Friday | News

Sartorius and MAbSilico Unite AI and Cell Line Development to Accelerate Biologics Discovery

Sartorius and MAbSilico are collaborating to connect Al-driven protein discovery with automated, high-throughput cell line development  The integrated workflow enables computational developability assessm...

Lab

21 September, 2026 | Monday | News

OGT Expands SureSeq NGS Indexing Capacity to 384 Samples per Run

OGT, a leading global provider of genomic research and diagnostic solutions, announced the expansion of its SureSeq™ Universal NGS Unique Dual Index (UDI) range, enabling laboratories to multiplex up to 3...

BioTech

02 October, 2026 | Friday | Analysis

Biotech Failures 2026: What Did Not Happen in APAC Biopharma

Approvals get counted, deals get ranked, listings get priced. The other half of the year, the programmes that stopped, the applications that came back, the partnerships that ended quietly in a footnote, rarely ...

Contract Services

05 October, 2026 | Monday | News

Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing for In Vivo Therapies

Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturing expertise. Integrated approach brings manufactur...

Consumer Health

06 October, 2026 | Tuesday | News

FDA Expands Lilly’s Jaypirca Approval to First-Line CLL/SLL Treatment

Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved an additional indication for Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets), a non-covalent B...

Medtech

02 October, 2026 | Friday | News

AsiaMedic Becomes First in ASEAN to Adopt GE HealthCare’s MR31 MRI Platform

Singapore imaging provider is the earliest site in the region to adopt a new generation of MRI technology. MR31 will enable AsiaMedic to reduce scan times and widen the range of complex examinations availabl...

Cell & Gene

30 September, 2026 | Wednesday | News

iRegene Advances Off-the-Shelf Retinal Cell Therapy Into Clinical Trials in US and China

 Following its Parkinson's disease program, iRegene advances another off-the-shelf cell therapy into clinical development in the U.S. and China. iRegene Therapeutics Co., Ltd. ("iRegene" or the "Company")...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close